Current role
Biotechnology · Healthcare
Chairman
2026-03-16–present
Vincent LoPriore
Chairman
Hepion Pharmaceuticals, Inc. (HEPA)Equibles does not estimate personal net worth.
Get an email with a short summary when Hepion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get HEPA alertsAbout Vincent LoPriore
Vincent LoPriore is recorded as Chairman at Hepion Pharmaceuticals, Inc. (HEPA) since March 16, 2026. Hepion Pharmaceuticals, Inc. reported in an 8-K filed March 18, 2026 that Vincent LoPriore was appointed Executive Chairman, effective March 16, 2026. Hepion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Hepion Pharmaceuticals, Inc. includes Dr. Kaouthar Lbiati (CEO), Gary Stetz (CEO, CFO and Board Member), John Cavan (CEO and CFO) and 7 others.
“On March 16, 2026, the Board approved the appointment of Gary Stetz as interim Chief Executive Officer of the Company and director and appointed Vincent LoPriore as Executive Chairman, Sireesh Appajosyula as director and Chase LoPriore as director.”
Affiliation history
-
Current
2026-03-16–present
Company network
Leadership on record at Hepion Pharmaceuticals, Inc.
- Dr. Kaouthar Lbiati CEO
- Gary Stetz CEO, CFO, Board Member
- John Cavan CEO, CFO
- Kaouthar Lbiati CEO, Board Member
- Sireesh Appajosyula CEO, Board Member
- John Brancaccio Chairman, CFO
- Chase LoPriore Board Member
- Danina Fisher Board Member
- Gary S. Stetz, II Board Member
- James Liddy Board Member